{"id":"W4405832650","doi":"10.1016/j.jcjd.2024.12.003","title":"Possible Drug Interaction Between Elexacaftor-Tezacaftor-Ivacaftor and Repaglinide in an Adult With Cystic Fibrosis–related Diabetes","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"Novo Nordisk Canada","keywords":"Ivacaftor; Medicine; Repaglinide; Cystic fibrosis; Diabetes mellitus; Drug; Cystic fibrosis-related diabetes; Type 2 diabetes; Pharmacology; Internal medicine; Endocrinology; Impaired glucose tolerance; Cystic fibrosis transmembrane conductance regulator","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004864265,0.0002809606,0.0006494338,0.0006779397,0.0008634445,0.0005753047,0.0004598275,0.001547775,0.002947334],"category_scores_gemma":[0.003172152,0.0001916225,0.0009457989,0.0005114546,0.0003769133,0.0005187785,0.0002949169,0.001384461,0.0002566687],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009009581,"about_ca_system_score_gemma":0.0007082148,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008911889,"about_ca_topic_score_gemma":0.01163638,"domain_scores_codex":[0.9994258,0.0001404894,0.0001137555,0.00008251637,0.0001537814,0.00008361135],"domain_scores_gemma":[0.9987121,0.0006037047,0.0003325768,0.00003411268,0.00008978936,0.0002278435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"case_report","study_design_scores_codex":[0.003738721,0.0008639253,0.5798056,0.0002778528,0.0005429138,0.375941,0.0006743597,0.0005136196,0.005024775,0.0008672495,0.002951994,0.02879799],"study_design_scores_gemma":[0.0004272354,0.003355311,0.4200118,0.0002097615,0.001600347,0.5541763,0.001372979,0.005175344,0.003165704,0.0009050242,0.009521417,0.00007876461],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9818375,0.004911956,0.0007602448,0.004520239,0.0001490678,0.00006409283,0.0003015695,0.00004433835,0.007410943],"genre_scores_gemma":[0.9959891,0.000950175,0.0006607593,0.001437024,0.0001896714,0.000008565233,0.0001155191,0.000006729549,0.0006424618],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008911889,"threshold_uncertainty_score":0.01771998,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009156732572055076,"score_gpt":0.2734598081311805,"score_spread":0.2643030755591254,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}